Clinical trials
Frailty trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 12 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 8 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 13 |
| Unknown status | 8 |
| Active, not recruiting | 3 |
| Withdrawn | 3 |
| Terminated | 1 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 8 |
| McMaster University | 5 |
| Nova Scotia Health Authority | 5 |
| University of Alberta | 4 |
| University of British Columbia | 4 |
| Jewish General Hospital | 3 |
| Ottawa Hospital Research Institute | 3 |
| University of Waterloo | 3 |
| Bruyère Health Research Institute. | 2 |
| University of New Brunswick | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Frailty | 58 |
| Cardiovascular Diseases | 6 |
| Hypertension | 4 |
| Sarcopenia | 4 |
| Cognitive Dysfunction | 3 |
| Heart Failure | 3 |
| Kidney Diseases | 3 |
| Neoplasms | 3 |
| Osteoporosis | 3 |
| Arthritis | 2 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.